Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2023 July-August;182(7-8) > Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2023 July-August;182(7-8):444-8

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Gazzetta Medica Italiana - Archivio per le Scienze Mediche 2023 July-August;182(7-8):444-8

DOI: 10.23736/S0393-3660.22.04961-0

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

Vitamin D biological activity index in COVID-19: current concept and future challenges

Zheina V. CHERNEVA 1, Vania M. YOUROUKOVA 2, Radostina V. CHERNEVA 3

1 Clinic of Cardiology, Medical Institute of the Ministry of Internal Affairs, Sofia, Bulgaria; 2 Clinic of Intensive Care, University Hospital for Respiratory Diseases St. Iv. Rilski, Medical University of Sofia, Sofia, Bulgaria; 3 Clinic of Pulmonology, University Hospital for Respiratory Diseases St. Iv. Rilski, Medical University of Sofia, Sofia, Bulgaria



Vitamin D helps our immunity to fight viruses and bacteria, thus reducing the risk of respiratory infections. It suppresses the excessive or dysfunctional activities of immunity and prevents autoimmune diseases. In animal models vitamin D increases ACE2 on the cell surface, so its protection may not apply to COVID-19 since SARS-CoV-2 enters human cells by binding ACE2. On the other hand, ACE2 might make COVID-19 less severe, as it protects against lung damage. Observational and ecological studies are controversial regarding the association vit D levels - COVID-19 severity. Contradictory are the results of the way it influences the rate and duration of hospitalizations, ICU admissions and mortality.


KEY WORDS: Vitamin D; Immunity; COVID-19

top of page